胸部肿瘤内一科，副主任医师 

专业擅长：

非小细胞肺癌，小细胞肺癌，胸膜间皮瘤，胸腺瘤/癌。

重要的社会兼职：

中国民族医药协会肿瘤学分会 副秘书长，北京慢性病防治与健康教育研究会分子靶向治疗专委会副秘书，北京医学奖励会肺癌青年委员会 秘书 

代表性成果：

课题：

主持北京肿瘤医院临床研究青年基金、吴阶平科研专项资助基金,参与国家自然科学基金委员会专项项目、面上项目、首都卫生发展科研专项等 

论文：

(1) The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer, Cancer Medicine, 2022, 11(19): 3592-3592

(2) Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients, Annals of Translational Medicine., 2021, 9(1): 33-33

(3) Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer: A real-world, multicenter, retrospective, controlled study in China, amp;nbsp;Chinese Journal of Cancer Research, 2022, 34(4): 353- 364

(4) Real-world evaluation of first-line treatment of extensivestage small-cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis, CLINICAL amp; TRANSLATIONAL ONCOLOGY, 2024, 26(7)

(5)  Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas, CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36(1): 90-102